ImmuCell* is a public biotechnology company dedicated to marketing products that improve animal health and productivity in the dairy and beef industries. Our product focus encompasses prevention, diagnosis and treatment of bovine diseases.

ImmuCell continues to be on the forefront of calf scours (diarrhea) prevention technology, manufacturing and marketing First Defense®, the most popular and convenient scours prevention administered to calves. It’s the only USDA approved scours preventative administered to calves with indications for E. coli and coronavirus.

ImmuCell is currently leveraging strengths in enteric disease and reproductive efficiency products to develop other products for herd health. A major concentration is in the area of mastitis management. ImmuCell’s Intelligent Mastitis Management™ program incorporates innovative products, along with some widely accepted testing tools, to help minimize the effects of mastitis.

ImmuCell also has corporate assets that were created from our R&D work in prior years. We are in the process of maximizing the value of these products while minimizing deviations from our core focus.